Laws & Regulations

Is the No Surprises Act Driving Up Health Insurance Costs?
Infrastructure & Management Is the No Surprises Act Driving Up Health Insurance Costs?

The current arbitration model incentivizes litigation over negotiation by allowing providers to consistently win payouts far above standard market rates. This systemic flaw has turned a legislative triumph for patient rights into a complex fiscal challenge that reverberates throughout the entire

Healthcare Leaders Face Security Gaps Amid Rise of Shadow AI
Regulatory & Compliance Healthcare Leaders Face Security Gaps Amid Rise of Shadow AI

The rapid proliferation of unmanaged artificial intelligence tools within hospital corridors has created a precarious digital landscape where innovation frequently bypasses the watchful eye of security experts. This surge in unsanctioned technology usage represents a fundamental challenge for

AtaCor Medical Launches Pivotal Study for New EV-ICD System
Infrastructure & Management AtaCor Medical Launches Pivotal Study for New EV-ICD System

This pivotal milestone in cardiac technology addresses the vulnerabilities of traditional systems by utilizing a small incision and a unique rib-space placement technique. Sudden cardiac death remains a significant global health challenge, affecting millions of people who require reliable

Can Singular Health Scale Its 3DICOM Platform in the US?
Regulatory & Compliance Can Singular Health Scale Its 3DICOM Platform in the US?

Singular Health Group is currently pursuing HITRUST certification to satisfy the stringent data privacy requirements often demanded by large-scale United States healthcare providers. This objective marks a definitive shift for the Australian med-tech firm as it moves beyond its research roots to

How Will Bexlutry Change the Treatment of GEP-NETs?
Imaging & Diagnostics How Will Bexlutry Change the Treatment of GEP-NETs?

Targeting somatostatin receptor-positive tumors of the foregut, midgut, and hindgut, Bexlutry utilizes lutetium-177 to deliver localized radiation directly to malignant cells. This recent approval by the U.S. Food and Drug Administration (FDA) represents a significant shift for Curium as it

Is U.S. Hospital Price Transparency Still a Distant Goal?
Infrastructure & Management Is U.S. Hospital Price Transparency Still a Distant Goal?

Navigating the American healthcare system often feels like walking through a grocery store where every price tag is hidden until the very moment the credit card is swiped at the exit counter. Despite years of federal mandates designed to pull back the curtain on medical costs, a staggering gap

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later